Literature DB >> 24470346

Human secreted stabilin-1-interacting chitinase-like protein aggravates the inflammation associated with rheumatoid arthritis and is a potential macrophage inflammatory regulator in rodents.

Weichun Xiao1, Geng Meng, Yanmei Zhao, Huihui Yuan, Tingting Li, Yanyan Peng, Yong Zhao, Ming Luo, Wenming Zhao, Zhanguo Li, Xiaofeng Zheng.   

Abstract

OBJECTIVE: To study the relationship between the human secreted protein stabilin-1-interacting chitinase-like protein (SI-CLP) and rheumatoid arthritis (RA).
METHODS: The expression of SI-CLP in peripheral blood mononuclear cells (PBMCs) and synovial fluid from patients with RA and the effects of cytokines on SI-CLP expression were examined by Western blotting. Fluorescence-activated cell sorting analysis was performed to investigate the binding between SI-CLP and cells. Bone marrow-derived macrophages were isolated from wild-type and SI-CLP(-/-) mice, and real-time quantitative polymerase chain reaction was performed to detect the levels of messenger RNA for cytokines or SI-CLP in SI-CLP- or cytokine-treated macrophages. Histologic studies were conducted to evaluate inflammation and the expression of interleukin-12 (IL-12), IL-13, and SI-CLP in lesions. Enzyme-linked immunosorbent assays were used to detect the cytokine levels in bone marrow-derived macrophages. Rats or mice with collagen-induced arthritis (CIA) and SI-CLP(-/-) mice were used to study the function of SI-CLP in RA.
RESULTS: SI-CLP expression was increased in PBMCs and detectable in synovial fluid from patients with RA. Administration of SI-CLP to rats with CIA aggravated arthritis-associated inflammation. SI-CLP was specifically attached to the surface protein of macrophages, which elevated the expression of IL-1β, IL-6, IL-12, and IL-13 in macrophages and mouse bone marrow-derived macrophages, up-regulating ERK phosphorylation. Moreover, SI-CLP was up-regulated by both IL-12 and IL-13 through JNK and JAK/STAT signaling, respectively. Knockout of SI-CLP resulted in a decrease in the expression of IL-1β, IL-6, IL-12, and IL-13 and lower susceptibility to CIA compared with wild-type mice. SI-CLP treatment also aggravated arthritis-related inflammation in wild-type and SI-CLP(-/-) mice.
CONCLUSION: SI-CLP functions as a regulator of the inflammatory response by macrophages. The decrease in inflammation-associated cytokine levels resulting from SI-CLP knockout may explain the lower susceptibility to CIA in SI-CLP(-/-) mice.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24470346     DOI: 10.1002/art.38356

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  5 in total

1.  Preliminary Study on Gene Expression of Chitinase-Like Cytokines in Human Airway Epithelial Cell Under Chitin and Chitosan Microparticles Treatment.

Authors:  Masumeh Alimohammadi; Farshid Yeganeh; Mostafa Haji Molla Hoseini
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 2.  Keeping track of the growing number of biological functions of chitin and its interaction partners in biomedical research.

Authors:  Bjørn E V Koch; Jens Stougaard; Herman P Spaink
Journal:  Glycobiology       Date:  2015-01-16       Impact factor: 4.313

Review 3.  Synovial Macrophages in Rheumatoid Arthritis: The Past, Present, and Future.

Authors:  Jiajie Tu; Xinming Wang; Xun Gong; Wenming Hong; Dafei Han; Yilong Fang; Yawei Guo; Wei Wei
Journal:  Mediators Inflamm       Date:  2020-04-13       Impact factor: 4.711

4.  Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern.

Authors:  Carolina Serena; Monica Millan; Miriam Ejarque; Alfonso Saera-Vila; Elsa Maymó-Masip; Catalina Núñez-Roa; Diandra Monfort-Ferré; Margarida Terrón-Puig; Michelle Bautista; Margarita Menacho; Marc Martí; Eloy Espin; Joan Vendrell; Sonia Fernández-Veledo
Journal:  Clin Epigenetics       Date:  2020-04-06       Impact factor: 6.551

Review 5.  YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer.

Authors:  Julia Kzhyshkowska; Irina Larionova; Tengfei Liu
Journal:  Front Immunol       Date:  2020-01-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.